Literature DB >> 30702258

Renal Cell Carcinoma: Diagnosis and Management.

Richard E Gray1, Gabriel T Harris1.   

Abstract

Kidney cancer is one of the 10 most common cancers in the United States with 90% being attributed to renal cell carcinoma. Men, especially black men, are more likely to be affected than women. Renal masses, either cystic or solid, are best detected with contrast-enhanced, triple-phase computed tomography. Renal tumors are often detected incidentally during a computed tomography scan of the abdomen or chest that was ordered for unrelated symptoms. Hematuria serves as a warning sign that necessitates further evaluation and imaging leading to a diagnosis and treatment plan. Treatment options include active surveillance, ablation, nephron-sparing tumor excision, nephrectomy, and systemic treatment. Predictors of a poor prognosis include poor functional status and metastasis. In recent years new therapies have improved the prognosis for patients with metastatic disease. The family physician should be aware of risk factors (e.g., hypertension, tobacco use, exposure to trichloroethylene, familial syndromes) and lifestyle and dietary modifications that may reduce risk.

Entities:  

Mesh:

Year:  2019        PMID: 30702258

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  49 in total

Review 1.  Gender Differences in Obesity-Related Cancers.

Authors:  Georgia Argyrakopoulou; Maria Dalamaga; Nikolaos Spyrou; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2021-02-01

2.  Studying the association between breast cancer and renal cell carcinoma.

Authors:  Khalid Jazieh; Firas Baidoun; Nataly Torrejon; Zahi Merjaneh; Anas Saad; Mohamed Gad; Amal Farouk; Moshe Ornstein; Jame Abraham
Journal:  Breast Cancer Res Treat       Date:  2021-12-02       Impact factor: 4.872

3.  MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.

Authors:  Pamposh Raina; S K Singh; Anil K Goswami; Manoj Kumar Kashyap; Madhu Khullar; S K Sharma; Kailash Chander Barwal
Journal:  Mol Cell Biochem       Date:  2021-10-30       Impact factor: 3.396

Review 4.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 5.  Renal Cell Carcinoma: A Complex Therapeutic Challenge in the Elderly.

Authors:  Mashood Iqbal
Journal:  Cureus       Date:  2022-06-26

6.  UBA2 promotes the progression of renal cell carcinoma by suppressing the p53 signaling.

Authors:  Xinbo Du; Jianguo Shi
Journal:  Ir J Med Sci       Date:  2021-08-31       Impact factor: 2.089

7.  SLC18A3 promoted renal cancer development through acetylcholine/cAMP signaling.

Authors:  Peng Tie; Ji Cheng; Miao-Xin Xue; Jian Yin; Guo Fu; Wan-Li Duan
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

8.  Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.

Authors:  Xiaobin Wu; Yonghui Liang; Xian Chen; Xiangyang Long; Wujun Xu; Li Liu; Binhui Wang; Xiong Zou
Journal:  J Immunol Res       Date:  2022-07-04       Impact factor: 4.493

9.  Initial Presentation of Renal Cell Carcinoma as Heart Failure Secondary to Tumor-Thrombus Extension to the Right Atrium.

Authors:  Keshav R Patel; Dilpat Kumar; Jagadeesh K Kalavakunta; Fnu Warsha
Journal:  Cureus       Date:  2021-04-17

10.  Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1.

Authors:  Chengluo Jin; Linmei Shi; Kunlun Li; Wei Liu; Yu Qiu; Yakun Zhao; Bai Zhao; Zhexun Li; Yifei Li; Qingguo Zhu
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.